Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — In this video, Nancy S. Reau, MD, FAASLD, AGAF, highlights a presentation at the ACG Annual ...

† Anti-IgG as secondary antibody. ‡ Anti-IgG1, IgG2 and IgG3 as secondary antibody. IB: Immunoblotting; IIF: Immunofluorescence; LBR: Lamin B receptor; NE: Nuclear envelope; NPC: Nuclear pore complex.

Primary biliary cholangitis (PBC) has typically been considered a rare condition, with a pooled global estimated incidence of two per 100,000 people per year and an estimated prevalence of 15 per ...

Primary biliary cholangitis (PBC), previously referred to as primary biliary cirrhosis, is an autoimmune disorder characterized by intrahepatic cholestasis. While the precise etiology and pathogenesis ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Livdelzi ® (seladelpar) ...

Please provide your email address to receive an email when new articles are posted on . The long-stagnant primary biliary cholangitis drug market has seen renewed attention in the past 3 months with ...

Systemic lupus erythematosus (SLE) and primary biliary cirrhosis (PBC) are both chronic autoimmune diseases. PBC primarily affects the liver and is characterized by inflammation or swelling of the ...

NEWARK, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (CBAY), a biopharmaceutical company focused on innovative therapies for patients with liver and other chronic diseases, ...

Cirrhosis is a chronic and progressive liver disease that occurs when scar tissue gradually replaces healthy liver tissue. Certain conditions, such as hepatitis B and C, can cause post-necrotic ...

Primary biliary cirrhosis (PBC) is a chronic, cholestatic liver disease characterized by progressive destruction of intrahepatic bile ducts, resulting in chronic cholestasis, portal inflammation and ...